ARTELUM

This brand name is authorized in Nigeria.

Active ingredients

The drug ARTELUM contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII C7D6T3H22J - ARTEMETHER
 

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.

 
Read more about Artemether
2
UNII F38R0JR742 - LUMEFANTRINE
 
Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-0930 Tablet Artelum Tablet TAB 80 mg; 480 mg 1 x 6's (in blister) Tablet 67 RNW-PP-438860 ARTELUM 80/480 TABLET A11-0930 ARTEMETHER 80MG LUMEFANTRINE 480MG Drugs N/A Yellow circular biconvex tablets with one side engraved with “ART” at the center and other side with “MBN” at the center. Absence of specks, chipping and capping 16 blister in a pack TABLET -- Select -- Anti Malaria 16 MAY & BAKER NIGERIA PLC 8033137565 tooluwasanmi@gmail.com SAPARA STREET, INDUSTRIAL ESTATE, IKEJA LAGOS LAGOS Nigeria Local May & Baker Nigeria Plc. Renewal 2.34709E+12 info@may-baker.com 1 MAY & BAKER AVENUE, OTA OGUN STATE 12/18/2024 Medium /Large Scale 12/17/2029 7/29/2024 30/01/2025
A4-0850 Tablet Artelum Tablet TAB 40 mg; 240 mg Tablet 10/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF01 Artemether and lumefantrine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-0930, A4-0850

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈